Use of Anti-inflammatory Analgesics Has a Positive Effect on Survival Outcomes in Ovarian Cancer
The use of anti-inflammatory analgesics, such as aspirin, may extend survival for patients with ovarian cancer.
The use of anti-inflammatory analgesics, such as aspirin, may extend survival for patients with ovarian cancer.
In the EBMT ALWP study, researchers sought to determine the efficacy of myeloablative conditioning to reduce the risk for post allogeneic HCT in patients with sAML without significantly increasing non-relapse mortality.
A retrospective study evaluated the efficacy vs pulmonary toxicity of brentuximab vedotin for relapsed or refractory Hodgkin lymphoma in pediatric patients.
Using the Questions on Life Satisfaction (FLZ-M) questionnaire, researchers determined the extent of life satisfaction across 10 subdomains reported by adolescents and young adults with cancer.
A retrospective analysis of outcomes demonstrated the influence of rituximab maintenance after R-CHOP or R-CVP for follicular lymphoma in elderly patients.
Outcomes data demonstrated the impact of socioeconomic status and insurance coverage on outcomes for patients with follicular lymphoma by age (younger than 65 and 65 and older).
Using a longitudinal parallel-process model, researchers evaluated the impact of physical activity on symptoms, physical activity, and cognitive function in children with ALL undergoing chemotherapy.
In a retrospective study conducted in the United States and the United Kingdom, researchers evaluated the prescribing of preventative medications in patients with lung cancer discharged from hospital at the end of life.
An increased body mass index (BMI) may negatively affect disease progression in patients with T1G3 non-muscle-invasive bladder cancer, according to study data.
Researchers sought to determine if the newly formed regimen RiBVD was effective and tolerable in patients older than 65 with mantle cell lymphoma.